platinum has been researched along with Nervous System Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L; Duanmu, W; Feng, H; Gao, F; Ge, H; Hu, R; Li, F; Tan, L; Tunan, C; Yin, Y; Yuan, J | 1 |
| Brown, R; He, Y; Hertz, DL; McLeod, HL; McWhinney-Glass, S; Motsinger-Reif, AA; Paul, J; Winham, SJ; Yen Revollo, J | 1 |
| Kim, CH; Kim, HT; Lee, JC; Park, YH; Ryoo, BY | 1 |
| Chang, HM; Choi, SJ; Kang, YK; Kim, TW; Kim, WK; Lee, JS; Park, YH; Ryu, BY | 1 |
| Le Quesne, PM | 1 |
| Edelstein, MB; Hussain, M; Wozniak, AJ | 1 |
| Hench, LL; Johnson, PF | 1 |
1 review(s) available for platinum and Nervous System Disorders
| Article | Year |
|---|---|
Neurotoxicity of antineoplastic agents.
Topics: Animals; Cisplatin; Humans; Immunologic Factors; Nervous System Diseases; Platinum; Vinca Alkaloids | 1993 |
2 trial(s) available for platinum and Nervous System Disorders
| Article | Year |
|---|---|
Gemcitabine and vinorelbine as second-line therapy for non-small cell lung cancer after treatment with paclitaxel plus platinum.
Topics: Adult; Aftercare; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Drug Administration Schedule; Feasibility Studies; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Platinum; Survival Rate; Vinblastine; Vinorelbine | 2004 |
Phase II study of paclitaxel and carboplatin in advanced gastric cancer previously treated with 5-fluorouracil and platinum.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Drug Administration Schedule; Endpoint Determination; Female; Fluorouracil; Humans; Male; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Platinum; Stomach Neoplasms | 2005 |
4 other study(ies) available for platinum and Nervous System Disorders
| Article | Year |
|---|---|
L-Borneol induces transient opening of the blood-brain barrier and enhances the therapeutic effect of cisplatin.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Camphanes; Capillary Permeability; Cisplatin; Claudin-5; Contrast Media; Disease Models, Animal; Dose-Response Relationship, Drug; Glioma; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Nervous System Diseases; Occludin; Platinum | 2017 |
Cumulative genetic risk predicts platinum/taxane-induced neurotoxicity.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Case-Control Studies; Female; Genetic Association Studies; Genotype; Humans; Nervous System Diseases; Odds Ratio; Ovarian Neoplasms; Platinum; Polymorphism, Single Nucleotide; Taxoids | 2013 |
Metal-induced diseases of the nervous system.
Topics: Aluminum; Alzheimer Disease; Animals; Arsenic Poisoning; Bismuth; Gold; Humans; Lead; Lead Poisoning; Manganese Poisoning; Mercury Poisoning; Metals; Methylmercury Compounds; Nervous System Diseases; Organometallic Compounds; Organotin Compounds; Platinum; Thallium | 1982 |
An in vitro analysis of metal electrodes for use in the neural environment.
Topics: Corrosion; Electric Conductivity; Electric Stimulation; Electrodes; Evaluation Studies as Topic; Gold; In Vitro Techniques; Iridium; Models, Biological; Nervous System Diseases; Platinum; Prostheses and Implants; Rhodium | 1977 |